Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence. [electronic resource]
Producer: 20110512Description: 14-22 p. digitalISSN:- 1549-490X
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Bevacizumab
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials as Topic
- Combined Modality Therapy
- Disease-Free Survival
- Everolimus
- Humans
- Immunotherapy -- methods
- Indoles -- therapeutic use
- Interferon-alpha -- therapeutic use
- Interleukin-2 -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Molecular Targeted Therapy -- methods
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- therapeutic use
- Pyrroles -- therapeutic use
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.